Insider Trading & Ownership - Cerevel Therapeutics Holdings Inc. (CERE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cerevel Therapeutics Holdings Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2024-01-02
Sale		 2024-01-04
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $42.24 $2,111,815 2,455,121
(Direct)		 View
2023-12-26
Sale		 2023-12-28
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $42.47 $424,700 553,108
(Direct)		 View
2023-12-22
Sale		 2023-12-27
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 8,000 $41.45 $331,608 326,905
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:27 pm		 Cerevel Therapeutics Holdings Inc. CERE Bodenrader Mark
See Remarks		 7,889 $41.42 $326,788 17,724
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:24 pm		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 6,256 $41.42 $259,144 24,663
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:21 pm		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 7,072 $41.42 $292,945 7,237
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:14 pm		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,152 $41.42 $420,528 14,673
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:12 pm		 Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer		 13,808 $41.42 $571,972 16,913
(Direct)		 View
2023-12-20
Sale		 2023-12-21
8:10 pm		 Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks		 6,288 $41.42 $260,469 7,516
(Direct)		 View
2023-12-15
Sale		 2023-12-19
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 7,500 $41.39 $310,393 123,390
(Direct)		 View
2023-12-07
Sale		 2023-12-11
4:17 pm		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $41.37 $413,700 548,435
(Direct)		 View
2023-12-05
Sale		 2023-12-07
7:45 pm		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 17,500 $38.64 $676,200 519,037
(Direct)		 View
2023-11-14
Sale		 2023-11-16
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 22,824 $25.13 $573,455 2,505,121
(Direct)		 View
2023-11-07
Sale		 2023-11-09
5:03 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 27,176 $25.02 $680,071 5,053,286
(Direct)		 View
2023-11-02
Sale		 2023-11-06
5:12 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 100,000 $25.34 $2,533,697 5,168,939
(Direct)		 View
2023-11-01
Sale		 2023-11-03
4:15 pm		 Cerevel Therapeutics Holdings Inc. CERE PATRICK DEVAL L
Director		 30,130 $25 $753,250 15,837
(Direct)		 View
2023-10-16
Purchase		 2023-10-18
4:30 pm		 Cerevel Therapeutics Holdings Inc. CERE Gordon Christopher R
Director
10% Owner		 5,480,052 $22.81 $124,999,986 65,683,063
(Indirect
Direct)		 View
2023-10-16
Purchase		 2023-10-18
4:30 pm		 Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
Director
10% Owner		 5,480,052 $22.81 $124,999,986 65,683,063
(Indirect
Direct)		 View
2023-10-16
Purchase		 2023-10-18
4:30 pm		 Cerevel Therapeutics Holdings Inc. CERE BAIN CAPITAL INVESTORS LLC
BC Perception Holdings LP
BCPE Perception GP LLC
Bain Capital Fund XII LP
Bain Capital Partners XII LLC
10% Owner		 5,480,052 $22.81 $124,999,986 65,679,781
(Indirect)		 View
2023-10-16
Purchase		 2023-10-17
4:53 pm		 Cerevel Therapeutics Holdings Inc. CERE PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director		 876,808 $22.81 $19,999,990 10,965,193
(Indirect)		 View
2023-09-07
Sale		 2023-09-08
4:35 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $24.07 $1,203,415 2,655,121
(Direct)		 View
2023-08-03
Purchase		 2023-08-07
5:13 pm		 Cerevel Therapeutics Holdings Inc. CERE Renaud Ronald C JR
President & CEO		 83,857 $23.96 $2,008,811 83,857
(Indirect)		 View
2023-08-04
Purchase		 2023-08-07
5:11 pm		 Cerevel Therapeutics Holdings Inc. CERE Burgess Paul D.
See Remarks		 21,880 $22.93 $501,794 21,880
(Direct)		 View
2023-07-11
Sale		 2023-07-13
5:41 pm		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $30.03 $1,501,340 2,705,121
(Direct)		 View
2023-06-15
Sale		 2023-06-20
4:56 pm		 Cerevel Therapeutics Holdings Inc. CERE DEKKERS MARIJN E
Director		 200,000 $34.43 $6,886,000 434,148
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-01-19
Option Award		 2024-01-23
5:50 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer		 87,573 $0 87,573
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:46 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks		 59,171 $0 59,171
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:45 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 63,905 $0 63,905
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:37 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Bodenrader Mark
See Remarks		 24,852 $0 24,852
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:37 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Burgess Paul D.
See Remarks		 81,065 $0 81,065
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:34 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 87,573 $0 87,573
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:31 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Renaud Ronald C JR
President & CEO		 284,023 $0 284,023
(Direct)		 View
2024-01-19
Option Award		 2024-01-23
5:31 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 59,171 $0 59,171
(Direct)		 View
2024-01-02
Exercise		 2024-01-04
4:15 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $0 2,455,121
(Direct)		 View
2024-01-02
Exercise		 2024-01-04
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $3.5 2,455,121
(Direct)		 View
2023-12-26
Exercise		 2023-12-28
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks		 3,150 $10.05 265,748
(Direct)		 View
2023-12-26
Exercise		 2023-12-28
4:15 pm		 N/A
2030-07-29		 Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks		 3,150 $0 265,748
(Direct)		 View
2023-12-26
Exercise		 2023-12-28
4:15 pm		 N/A
2029-02-27		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $0 553,108
(Direct)		 View
2023-12-26
Exercise		 2023-12-28
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $3.5 553,108
(Direct)		 View
2023-12-22
Exercise		 2023-12-27
4:15 pm		 N/A
2029-04-02		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 8,000 $0 326,905
(Direct)		 View
2023-12-22
Exercise		 2023-12-27
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 8,000 $3.5 326,905
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:27 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Bodenrader Mark
See Remarks		 19,284 $0 17,724
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:26 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Burgess Paul D.
See Remarks		 23,847 $0 45,727
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:24 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer		 13,913 $0 24,663
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:21 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 13,796 $0 7,237
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:18 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Renaud Ronald C JR
President & CEO		 160,452 $0 244,309
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:14 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 24,825 $0 14,673
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:12 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE ALTSCHULLER Susan
Chief Financial Officer		 30,721 $0 16,913
(Direct)		 View
2023-12-19
Exercise		 2023-12-21
8:10 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks		 13,804 $0 7,516
(Direct)		 View
2023-12-15
Exercise		 2023-12-19
4:15 pm		 N/A
2030-10-28		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 7,500 $0 123,390
(Direct)		 View
2023-12-15
Exercise		 2023-12-19
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 7,500 $9.88 123,390
(Direct)		 View
2023-12-07
Exercise		 2023-12-11
4:17 pm		 N/A
2029-02-27		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $0 548,435
(Direct)		 View
2023-12-07
Exercise		 2023-12-11
4:17 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer		 10,000 $3.5 548,435
(Direct)		 View
2023-12-05
Exercise		 2023-12-07
7:45 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 17,500 $13.17 519,037
(Direct)		 View
2023-12-05
Exercise		 2023-12-07
7:45 pm		 N/A
2031-06-01		 Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer		 17,500 $0 519,037
(Direct)		 View
2023-11-14
Exercise		 2023-11-16
4:15 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 22,824 $0 2,505,121
(Direct)		 View
2023-11-14
Exercise		 2023-11-16
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 22,824 $3.5 2,505,121
(Direct)		 View
2023-11-07
Exercise		 2023-11-09
5:03 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 27,176 $0 5,053,286
(Direct)		 View
2023-11-07
Exercise		 2023-11-09
5:03 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 27,176 $3.5 5,053,286
(Direct)		 View
2023-11-02
Exercise		 2023-11-06
5:12 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 100,000 $0 5,168,939
(Direct)		 View
2023-11-02
Exercise		 2023-11-06
5:12 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 100,000 $3.5 5,168,939
(Direct)		 View
2023-11-01
Exercise		 2023-11-03
4:15 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE PATRICK DEVAL L
Director		 30,130 $12.62 15,837
(Direct)		 View
2023-11-01
Exercise		 2023-11-03
4:15 pm		 N/A
2031-02-01		 Cerevel Therapeutics Holdings Inc. CERE PATRICK DEVAL L
Director		 30,130 $0 15,837
(Direct)		 View
2023-09-07
Exercise		 2023-09-08
4:35 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $0 2,655,121
(Direct)		 View
2023-09-07
Exercise		 2023-09-08
4:35 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $3.5 2,655,121
(Direct)		 View
2023-07-11
Exercise		 2023-07-13
5:41 pm		 N/A
2028-12-24		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $0 2,705,121
(Direct)		 View
2023-07-11
Exercise		 2023-07-13
5:41 pm		 N/A
N/A		 Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
Director		 50,000 $3.5 2,705,121
(Direct)		 View
2023-07-03
Option Award		 2023-07-06
4:16 pm		 N/A
2033-07-03		 Cerevel Therapeutics Holdings Inc. CERE Burgess Paul D.
See Remarks		 119,778 $0 119,778
(Direct)		 View
2023-06-12
Option Award		 2023-06-14
4:53 pm		 N/A
2033-06-12		 Cerevel Therapeutics Holdings Inc. CERE Renaud Ronald C JR
President & CEO		 536,572 $0 536,572
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, 5, Next